Adhesion of Lidocaine Topical System 1.8%

NCT04312750 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Scilex Pharmaceuticals, Inc.